Combination of phosphorylated and truncated EGFR correlates with higher tumor and nodal stage in head and neck cancer

James Keller, Kenneth R. Shroyer, Shishir K. Batajoo, Hongling Zhao, Li Ming Dong, Michael J. Hayman, Edward L. Chan

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Epidermal growth factor receptor (EGFR) is a target in head and neck cancer. High EGFR expression and phosphorylated EGFR predicts poor survival in head and neck cancer patients, but does not correlate with advanced stage disease. The aim of this study is to determine if clinical biological correlates are more accurate when different aspects of EGFR are evaluated in combination. We analyzed the EGFR phosphorylation, expression, and mutations in 60 primary head and neck tumors. We not only found that head and neck tumors with either truncated or activated EGFR tend to have higher tumor and nodal stage but also discovered two novel EGFR truncations.

Original languageEnglish (US)
Pages (from-to)1054-1062
Number of pages9
JournalCancer Investigation
Volume28
Issue number10
DOIs
StatePublished - Nov 2010
Externally publishedYes

Fingerprint

Head and Neck Neoplasms
Epidermal Growth Factor Receptor
Neoplasms
Neck
Head
Phosphorylation
Mutation
Survival

Keywords

  • EGFRvIII
  • Head and neck squamous cell carcinomas
  • Phosphorylated EGFR
  • Truncated EGFR
  • Tyrosine kinase receptor

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Combination of phosphorylated and truncated EGFR correlates with higher tumor and nodal stage in head and neck cancer. / Keller, James; Shroyer, Kenneth R.; Batajoo, Shishir K.; Zhao, Hongling; Dong, Li Ming; Hayman, Michael J.; Chan, Edward L.

In: Cancer Investigation, Vol. 28, No. 10, 11.2010, p. 1054-1062.

Research output: Contribution to journalArticle

Keller, James ; Shroyer, Kenneth R. ; Batajoo, Shishir K. ; Zhao, Hongling ; Dong, Li Ming ; Hayman, Michael J. ; Chan, Edward L. / Combination of phosphorylated and truncated EGFR correlates with higher tumor and nodal stage in head and neck cancer. In: Cancer Investigation. 2010 ; Vol. 28, No. 10. pp. 1054-1062.
@article{301bb645165642e791a7c351c798b514,
title = "Combination of phosphorylated and truncated EGFR correlates with higher tumor and nodal stage in head and neck cancer",
abstract = "Epidermal growth factor receptor (EGFR) is a target in head and neck cancer. High EGFR expression and phosphorylated EGFR predicts poor survival in head and neck cancer patients, but does not correlate with advanced stage disease. The aim of this study is to determine if clinical biological correlates are more accurate when different aspects of EGFR are evaluated in combination. We analyzed the EGFR phosphorylation, expression, and mutations in 60 primary head and neck tumors. We not only found that head and neck tumors with either truncated or activated EGFR tend to have higher tumor and nodal stage but also discovered two novel EGFR truncations.",
keywords = "EGFRvIII, Head and neck squamous cell carcinomas, Phosphorylated EGFR, Truncated EGFR, Tyrosine kinase receptor",
author = "James Keller and Shroyer, {Kenneth R.} and Batajoo, {Shishir K.} and Hongling Zhao and Dong, {Li Ming} and Hayman, {Michael J.} and Chan, {Edward L.}",
year = "2010",
month = "11",
doi = "10.3109/07357907.2010.512602",
language = "English (US)",
volume = "28",
pages = "1054--1062",
journal = "Cancer Investigation",
issn = "0735-7907",
publisher = "Informa Healthcare",
number = "10",

}

TY - JOUR

T1 - Combination of phosphorylated and truncated EGFR correlates with higher tumor and nodal stage in head and neck cancer

AU - Keller, James

AU - Shroyer, Kenneth R.

AU - Batajoo, Shishir K.

AU - Zhao, Hongling

AU - Dong, Li Ming

AU - Hayman, Michael J.

AU - Chan, Edward L.

PY - 2010/11

Y1 - 2010/11

N2 - Epidermal growth factor receptor (EGFR) is a target in head and neck cancer. High EGFR expression and phosphorylated EGFR predicts poor survival in head and neck cancer patients, but does not correlate with advanced stage disease. The aim of this study is to determine if clinical biological correlates are more accurate when different aspects of EGFR are evaluated in combination. We analyzed the EGFR phosphorylation, expression, and mutations in 60 primary head and neck tumors. We not only found that head and neck tumors with either truncated or activated EGFR tend to have higher tumor and nodal stage but also discovered two novel EGFR truncations.

AB - Epidermal growth factor receptor (EGFR) is a target in head and neck cancer. High EGFR expression and phosphorylated EGFR predicts poor survival in head and neck cancer patients, but does not correlate with advanced stage disease. The aim of this study is to determine if clinical biological correlates are more accurate when different aspects of EGFR are evaluated in combination. We analyzed the EGFR phosphorylation, expression, and mutations in 60 primary head and neck tumors. We not only found that head and neck tumors with either truncated or activated EGFR tend to have higher tumor and nodal stage but also discovered two novel EGFR truncations.

KW - EGFRvIII

KW - Head and neck squamous cell carcinomas

KW - Phosphorylated EGFR

KW - Truncated EGFR

KW - Tyrosine kinase receptor

UR - http://www.scopus.com/inward/record.url?scp=78649312092&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78649312092&partnerID=8YFLogxK

U2 - 10.3109/07357907.2010.512602

DO - 10.3109/07357907.2010.512602

M3 - Article

C2 - 20873989

AN - SCOPUS:78649312092

VL - 28

SP - 1054

EP - 1062

JO - Cancer Investigation

JF - Cancer Investigation

SN - 0735-7907

IS - 10

ER -